Sugi Predict

Sugi Predict / Compounds / SCHEMBL12608111

SCHEMBL12608111

SCHEMBL12608111

Brc1cncc(-c2cccs2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.56
▸ CYP2E1 P05181 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2B6 P20813 1/20 0.56
▸ MAPT P10636 6/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ TDP1 Q9NUW8 4/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ PPARG P37231 1/20 0.44
▸ NCOA2 Q15596 1/20 0.44
▸ NCOA1 Q15788 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ NCOA3 Q9Y6Q9 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30613331 1.00 CYP2A6 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL1357023 0.86 CYP2A6 (0.67) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL9193569 0.78 KCNH2 (0.48) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL1334676 0.78 KCNH2 (0.48) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL4135586 0.78 CYP2C9 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL7423578 0.78 CYP3A4 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL12608100 0.78 CYP2E1 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL26387047 0.78 CYP2E1 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL4135591 0.78 CYP2A6 (0.56) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6
SCHEMBL1590727 0.75 KCNH2 (0.50) CYP2A6CYP2E1CYP3A4CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747247-A1 NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF Apogee Pharmaceuticals, Inc. (CA) 2026-05-27 — — EP disclosed
US-20250281465-A1 MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-09-11 — — US disclosed
US-12410137-B2 Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof APOGEE PHARMACEUTICALS, INC. (CA) 2025-09-09 — — US disclosed
US-20250129027-A1 FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2025-04-24 — — US disclosed
WO-2025015420-A1 NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2025-01-23 — — WO disclosed
WO-2023212095-A1 MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-11-02 — — WO disclosed
CN-111777571-B Synthesis method of chiral 2-amino-3- (1, 3-benzothiazole-2-yl) propionic acid hydrochloride 武汉药明康德新药开发有限公司 2023-07-11 — — CN disclosed
CN-111777571-A Synthesis method of chiral 2-amino-3- (1, 3-benzothiazole-2-yl) propionic acid hydrochloride 武汉药明康德新药开发有限公司 2020-10-16 — — CN disclosed
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 — — EP disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 — — WO disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 — — EP disclosed
CN-102958918-A Novel nicotinamide derivatives or salts thereof FUJIFILM CORP 2013-03-06 — — CN disclosed
US-20110118483-A1 n-Type thiophene semiconductors POLYERA CORPORATION 2011-05-19 — — US disclosed
US-20110118483-A1 n-Type thiophene semiconductors POLYERA CORPORATION 2011-05-19 — — US disclosed
US-7842198-B2 n-Type thiophene semiconductors NORTHWESTERN UNIVERSITY (US) 2010-11-30 — — US disclosed
US-7842198-B2 n-Type thiophene semiconductors NORTHWESTERN UNIVERSITY (US) 2010-11-30 — — US disclosed
US-20080293937-A1 n-Type Thiophene Semiconductors POLYERA CORPORATION 2008-11-27 — — US disclosed
US-20080293937-A1 n-Type Thiophene Semiconductors POLYERA CORPORATION 2008-11-27 — — US disclosed
US-7374702-B2 n-Type thiophene semiconductors NORTHWESTERN UNIVERSITY (US) 2008-05-20 — — US disclosed
US-7374702-B2 n-Type thiophene semiconductors NORTHWESTERN UNIVERSITY (US) 2008-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129027-A1 FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF FAAH, FAAH2, MGLL CYP2A6 232/4885CYP2E1 349/4885CYP3A4 654/4885
US-12410137-B2 Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof FAAH, FAAH2, MGLL CYP2A6 232/4885CYP2E1 349/4885CYP3A4 654/4885
US-20250281465-A1 MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE ORAI1, CHERP, CASR CYP2A6 4830/4885CYP2E1 4857/4885CYP3A4 4855/4885
US-20080293937-A1 n-Type Thiophene Semiconductors FTH1, FECH, CD2 CYP2A6 564/4885CYP2E1 1224/4885CYP3A4 458/4885
US-20110118483-A1 n-Type thiophene semiconductors FTH1, FECH, CD2 CYP2A6 564/4885CYP2E1 1224/4885CYP3A4 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.